Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F5VFS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,411
Award facts
- Contract value 100% obligated
- $15,410.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $15,410.86 delivery order (4570516922) to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of January 15, 2026. The contract utilizes firm fixed-price pricing and was awarded on a competitive, non-set-aside basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical supplier to federal military and veteran healthcare systems. The company is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the underlying vehicle for this delivery order.
This delivery order represents a routine pharmaceutical procurement under the broader DLA Troop Support Medical IDC, which provides comprehensive global pharmaceutical support for military healthcare programs worldwide. Enbrel is a biologic immunosuppressant medication primarily used in the treatment of rheumatoid arthritis and other inflammatory conditions, making it a critical therapeutic agent for military medical treatment facilities. The short completion timeline (one day) is typical for pharmaceutical delivery orders under established IDCs, reflecting the DLA's need for rapid fulfillment of healthcare commodities to support ongoing military medical operations and veteran care programs.
Quick answers
Who was awarded contract SPE2DR26F5VFS?
SPE2DR26F5VFS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F5VFS worth?
The government has obligated $15,411 on SPE2DR26F5VFS.
Is contract SPE2DR26F5VFS an order under another contract?
Yes. SPE2DR26F5VFS is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5VFS competed?
The extent of competition for SPE2DR26F5VFS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award